Aquamarine Financial (Cayman) Ltd
Grand Cayman, E9 · CIK 2104187 · 13F filing filed 2026-01-12
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Legal entityAQUAMARINE FINANCIAL (CAYMAN) LTD (KY)
- Kindhedge funds
- FamilyAquamarine Financial (Cayman) Ltd · 2 related pages
$974.7m
reported value
11positions
100.0%in top 10
—no comparable previous quarter
Holdings, Q3 2025
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| BANCO BRADESCO S A BBD | $477.1m48.95% | First filing |
| YPF SOCIEDAD ANONIMA YPF | $315.1m32.33% | First filing |
| GERDAU SA GGB | $55.2m5.66% | First filing |
| BANCO SANTANDER BRASIL S A BSBR | $50.3m5.16% | First filing |
| GRUPO FINANCIERO GALICIA S.A GGAL | $36.7m3.77% | First filing |
| BANCO MACRO SA BMA | $19.3m1.98% | First filing |
| COSAN S A CSANY | $10.3m1.06% | First filing |
| ORAMED PHARMACEUTICALS INC ORMP | $5.2m0.53% | First filing |
| BANCO BBVA ARGENTINA S A BBAR | $4.7m0.48% | First filing |
| TRANSPORTADORA DE GAS SUR TGS | $624.5k0.06% | First filing |
| CENTRAL PUERTO S A CEPU | $154.7k0.02% | First filing |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| ORAMED PHARMACEUTICALS INC ORMP · 13G · filed 2026-08-14 | 6.0%≈ $12.1m |
| PULSENMORE LTD PLSM · 13G · filed 2026-10-08 | 5.0% |